eFFECTOR Therapeutics Inc - Units (1 Ord Share Class A & 1/3 War)
LWACU
Get informed when a big investor buys or sells
+ FollowMarket Cap$316.59M
Close$
Share Statistics
| Market cap | $316.59 Million |
|---|---|
| Enterprise Value | $315.97 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.12 |
| Beta | 0.08 |
| Outstanding Shares | 30,075,000 |
Return
| Return on Equity | 1.61% |
|---|---|
| Return on Assets | 1.55% |
| Return on Invested Capital | -0.14% |
Valuation & Multiples
| P/E Ratio | 39.58 |
|---|---|
| PEG | -1.04 |
| Price to Sales | - |
| Price to Book Ratio | 1.52 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -986.82 |
| Enterprise Value to Net Income | 91 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About eFFECTOR Therapeutics Inc
CEO: Steve Worland Locust Walk Acquisition Corp. is a blank-check company formed for the purpose of acquiring or merging with one or more businesses,